Forte Biosciences
FBRX
33 hedge funds and large institutions have $10.2M invested in Forte Biosciences in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
3% more funds holding
Funds holding: 32 → 33 (+1)
0% less ownership
Funds ownership: 2.09% → 2.09% (-0%)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
23% less capital invested
Capital invested by funds: $13.3M → $10.2M (-$3.04M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$22.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$15.7K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.68K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.86K |
| 5 |
Morgan Stanley
New York
|
+$1.81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
-$17.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$13K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$7.74K |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$7.27K |
| 5 |
State Street
Boston,
Massachusetts
|
-$2.65K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Osaic Holdings
Scottsdale,
Arizona
| $582 | – | – | – |
|
27
Russell Investments Group
London,
United Kingdom
| $243 | – | – | – |
|
28
Bank of America
Charlotte,
North Carolina
| $142 | +$178 | +11 | New |
|
|
LWCFA
29
Loring Wolcott & Coolidge Fiduciary Advisors
Boston,
Massachusetts
| $112 | – | – | – |
|
30
Fidelity Investments
Boston,
Massachusetts
| $69 | +$81 | +5 | New |
|
|
RFG
31
REAP Financial Group
Austin,
Texas
| $52 | – | – | – |
|
32
JP Morgan Chase
New York
| $9 | – | – | – |
|
33
Qube Research & Technologies (QRT)
London,
United Kingdom
| $2 | – | – | – |
|
|
34
Two Sigma Advisers
New York
| – | -$17.3K | -992 | Closed |
|
|
TSS
35
Two Sigma Securities
New York
| – | -$7.74K | -445 | Closed |
|
36
Wells Fargo
San Francisco,
California
| – | -$176 | -10 | Closed |
|
FBRX Hedge Fund Activity: Q2 2024 in Review
33 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q2 2024, worth a combined $10.2M — down 23% from $13.3M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new FBRX positions and 3 closed out — a net gain of 1 holder — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $22.2K. The largest seller was Two Sigma Advisers, exiting entirely with an estimated $17.3K sold.
- 33 institutional investors held Forte Biosciences (FBRX) as of Q2 2024, up from 32 in Q1 2024.
- Funds reported $10.2M of Forte Biosciences stock for Q2 2024, down 23% quarter-over-quarter.
- 4 funds opened new Forte Biosciences positions in Q2 2024 and 3 closed out, a net change of +1 holder.
- The largest Forte Biosciences buyer in Q2 2024 was Susquehanna International Group, an estimated $22.2K added.
- The largest Forte Biosciences seller in Q2 2024 was Two Sigma Advisers, an estimated $17.3K sold.
Based on aggregated 13F filings for Q2 2024.